Drug retention and stability of solid lipid nanoparticles containing azidothymidine palmitate after autoclaving, storage and lyophilization

Journal of Microencapsulation
H HeiatiN C Phillips

Abstract

Solid lipid nanoparticles (SLNs) were prepared using trilaurine (TL) as the SLN core and phospholipid (PL) as coating. Neutral and negatively charged PLs were used to produce neutral and negatively charged SLNs. An ester prodrug of 3'-azido-3'-deoxythymidine (Zidovudine, AZT), AZT palmitate (AZT-P), was synthesized and incorporated in the SLNs. The stability of SLN formulations containing AZT-P was studied at different temperatures. Drug retention and mean particle diameter of SLNs were determined after autoclaving, during temperature stability testing, and after lyophilization (with or without cryoprotective sugars) and reconstitution. There were no significant changes in the mean diameter and the zeta potential (zeta) of SLNs after autoclaving (121 degrees C for 20 min). The amount of incorporated AZT-P was, however, slightly reduced due to the formation of hydrosoluble AZT. Autoclaved SLNs were stable for a period of 10 weeks at 20 degrees C but an increase in particle size and loss of AZT-P were observed at 4 and 37 degrees C. Trehalose was an effective cryoprotectant for preventing SLN aggregation during lyophilization and subsequent reconstitution. Thermal gravimetric analysis showed that lyophilized preparations containe...Continue Reading

References

Apr 1, 1991·Journal of Microencapsulation·E S Vuaridel-Bonanomi, H G Weder
May 9, 1990·Biochimica Et Biophysica Acta·H H de JonghD Marsh
Mar 1, 1990·Biophysical Journal·K Muldrew, L E McGann
Feb 1, 1990·The Journal of Hand Surgery : Journal of the British Society for Surgery of the Hand·D Marsh
Jun 1, 1990·Journal of Pharmaceutical Sciences·T KawaguchiK Juni
Apr 1, 1986·The Journal of Pharmacy and Pharmacology·J HigginsA J Phillips
Dec 22, 1988·Biochimica Et Biophysica Acta·L M Crowe, J H Crowe
Jun 9, 1988·Biochimica Et Biophysica Acta·J H CroweT J Anchordoguy
May 1, 1986·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J P SculierJ Frühling
Jan 1, 1985·Archives of Biochemistry and Biophysics·L M CroweD Chapman
Oct 1, 1985·Archives of Biochemistry and Biophysics·L M CroweL Appel
Jan 1, 1984·Pharmacology & Therapeutics·J N Weinstein, L D Leserman
Oct 15, 1983·Journal of Molecular Biology·E N SerrallachG G Shipley
Mar 14, 1993·Biochimica Et Biophysica Acta·D L Bernik, E A Disalvo
Nov 1, 1994·Journal of Microencapsulation·A N Lukyanov, V P Torchilin
Nov 1, 1993·Pharmaceutical Research·N J ZuidamD J Crommelin
Apr 8, 1993·Biochimica Et Biophysica Acta·S N SarkarS K Sikdar

❮ Previous
Next ❯

Citations

Apr 28, 2004·Advanced Drug Delivery Reviews·S A WissingR H Müller
Jul 11, 2003·Biomaterials·Béatrice HeurtaultJean-Pierre Benoit
Dec 6, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·C OlbrichC Kneuer
Apr 20, 2001·Advanced Drug Delivery Reviews·W Mehnert, K Mäder
Jun 27, 2000·International Journal of Pharmaceutics·Q ZhangT Nagai
Mar 19, 2002·International Journal of Pharmaceutics·M IgartuaJ P Benoit
Oct 16, 2003·International Journal of Pharmaceutics·M SametiC-M Lehr
Mar 25, 1999·International Journal of Pharmaceutics·C Olbrich, R H Müller
Jun 7, 2000·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·R H MüllerS Gohla
Aug 28, 2001·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·E Zimmermann, R H Müller
Jan 29, 2003·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Patrick ShahgaldianPhilippe Goreloff
May 9, 2000·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·V JenningS H Gohla
Apr 6, 2007·AAPS PharmSciTech·Neera JainSamuel H Yalkowsky
Dec 22, 2010·AAPS PharmSciTech·Surajit Das, Anumita Chaudhury
Oct 22, 2011·International Journal of Molecular Sciences·Chih-Chien LinChiu-Wen Chen
Mar 20, 2001·Journal of Microencapsulation·V Jenning, S H Gohla
Feb 6, 2010·Journal of Liposome Research·Hossein BaraniNasrin Samadi
Apr 5, 2013·Expert Opinion on Drug Delivery·Medha PatelKamalinder K Singh
May 25, 2010·Drug Delivery·Ali SeyfoddinRaida Al-Kassas
Jan 13, 2012·Drug Development and Industrial Pharmacy·Melissa D HowardThomas D Dziubla
May 14, 2014·Advanced Drug Delivery Reviews·David CipollaAnthony Hickey
Apr 6, 2013·Journal of Pharmaceutical Sciences·Navid MosallaeiBizhan Malaekeh-Nikouei
Aug 7, 2010·Colloids and Surfaces. B, Biointerfaces·Aditya P NayakEliana B Souto
Nov 17, 2009·Advanced Drug Delivery Reviews·José das NevesBruno Sarmento
Oct 27, 2015·International Journal of Pharmaceutics·Noha S El-SalamouniSafaa S El-Gamal
Oct 23, 2008·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·A del Pozo-RodríguezJ L Pedraz
Mar 21, 2007·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Eleonora VighiEliana Leo
Sep 2, 2015·International Journal of Pharmaceutics·Shilpa KakkarIndu Pal Kaur
May 22, 2016·Materials Science & Engineering. C, Materials for Biological Applications·Megdi EltayebAnthony Harker
Dec 17, 2011·Journal of Drug Delivery·Patrícia SeverinoEliana B Souto
Sep 7, 2013·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·S WeberJ Pardeike
Apr 4, 2015·International Journal of Pharmaceutical Investigation·K Viveksarathi, K Kannan
Jan 13, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Marcelo B de Jesus, Inge S Zuhorn
Mar 10, 2016·International Journal of Toxicology·David W HobsonRobin C Guy
Apr 23, 2013·Small·Mehmet H UcisikUwe B Sleytr
Jun 25, 2019·Current Medicinal Chemistry·Bruno Fonseca-SantosMarlus Chorilli
Feb 13, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Hilda Amekyeh, Nashiru Billa
Jan 23, 2021·International Journal of Molecular Sciences·Marta GueriniPaola Perugini
May 1, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Sergio A Bernal-ChávezGerardo Leyva-Gómez

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V
C Freitas, Rainer H Müller
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
R CavalliM R Gasco
© 2022 Meta ULC. All rights reserved